Routine Production of 89Zr Using an Automated Module
Open Access
- 12 July 2013
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 3 (3) , 593-613
- https://doi.org/10.3390/app3030593
Abstract
89Zr has emerged as a useful radioisotope for targeted molecular imaging via positron emission tomography (PET) in both animal models and humans. This isotope is particularly attractive for cancer research because its half-life (t1/2 = 3.27 days) is well-suited for in vivo targeting of macromolecules and nanoparticles to cell surface antigens expressed by cancer cells. Furthermore, 89Zr emits a low-energy positron (Eβ+,mean = 0.40 MeV), which is favorable for high spatial resolution in PET, with an adequate branching ratio for positron emission (BR = 23%). The demand for 89Zr for research purposes is increasing; however, 89Zr also emits significant gamma radiation (Γ15 keV = 6.6 R×cm2/mCi×h), which makes producing large amounts of this isotope by hand unrealistic from a radiation safety standpoint. Fortunately, a straightforward method exists for production of 89Zr by bombarding a natural Y target in a biomedical cyclotron and then separation of 89Zr from the target material by column chromatography. The chemical separation in this method lends itself to remote processing using an automated module placed inside a hot cell. In this work, we have designed, built and commissioned a module that has performed the chemical separation of 89Zr safely and routinely, at activities in excess of 50 mCi, with radionuclidic purity > 99.9% and satisfactory effective specific activity (ESA).Keywords
This publication has 49 references indexed in Scilit:
- Review on Production of 89Zr in a Medical Cyclotron for PET RadiopharmaceuticalsJournal of Nuclear Medicine Technology, 2013
- PET imaging with 89Zr: From radiochemistry to the clinicPublished by Elsevier ,2012
- The Rise of Metal Radionuclides in Medical Imaging: Copper-64, Zirconium-89 and Yttrium-86Future Medicinal Chemistry, 2011
- Immuno-Positron Emission Tomography: Shedding Light on Clinical Antibody TherapyCancer Biotherapy & Radiopharmaceuticals, 2010
- Positive Progress in ImmunoPET—Not Just a CoincidenceCancer Biotherapy & Radiopharmaceuticals, 2010
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of DiseaseChemical Reviews, 2010
- Image-Quality Assessment for Several Positron Emitters Using the NEMA NU 4-2008 Standards in the Siemens Inveon Small-Animal PET ScannerJournal of Nuclear Medicine, 2010
- Radioimmunoimaging with Longer-Lived Positron-Emitting Radionuclides: Potentials and ChallengesBioconjugate Chemistry, 2009
- Immuno-PET: A Navigator in Monoclonal Antibody Development and ApplicationsThe Oncologist, 2007
- Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992